Standout Papers

<sup>68</sup>Ga-FAPI PET/CT: Tr... 2005 2026 2012 2019 920
  1. 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer (2019)
    Clemens Kratochwil, Paul Flechsig et al. Journal of Nuclear Medicine
  2. Colorectal cancer (2005)
    Jürgen Weitz, Moritz Koch et al. The Lancet
  3. The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer (2014)
    Ali Afshar‐Oromieh, Frederik L. Giesel et al. European Journal of Nuclear Medicine and Molecular Imaging
  4. Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer (2013)
    Ali Afshar‐Oromieh, Christian M. Zechmann et al. European Journal of Nuclear Medicine and Molecular Imaging
  5. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein (2018)
    Thomas Lindner, Anastasia Loktev et al. Journal of Nuclear Medicine
  6. Radiation oncology in the era of precision medicine (2016)
    Michaël Baumann, Mechthild Krause et al. Nature reviews. Cancer
  7. A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts (2018)
    Anastasia Loktev, Thomas Lindner et al. Journal of Nuclear Medicine
  8. 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers (2018)
    Frederik L. Giesel, Clemens Kratochwil et al. Journal of Nuclear Medicine
  9. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience (2015)
    Tadashi Kamada, Hirohiko Tsujii et al. The Lancet Oncology
  10. Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients (2017)
    Ali Afshar‐Oromieh, Tim Holland‐Letz et al. European Journal of Nuclear Medicine and Molecular Imaging
  11. Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention (2019)
    Anastasia Loktev, Thomas Lindner et al. Journal of Nuclear Medicine
  12. MR-guidance in clinical reality: current treatment challenges and future perspectives (2019)
    Stefanie Corradini, Filippo Alongi et al. Radiation Oncology

Immediate Impact

2 by Nobel laureates 4 from Science/Nature 74 standout
Sub-graph 1 of 19

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Nanomedicine Tumor Targeting
2024 Standout
38 intermediate papers

Works of Jürgen Debus being referenced

Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
2008
Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems
2006
and 32 more

Author Peers

Author Last Decade Papers Cites
Jürgen Debus 19292 9878 12251 12013 1.3k 42.3k
Walter J. Curran 19192 5212 7926 10223 661 36.0k
Minesh P. Mehta 25249 4945 6296 10314 1.1k 44.1k
Philippe Lambin 16811 5686 28367 8749 705 44.5k
Søren M. Bentzen 11847 8159 10094 7261 530 28.5k
Markus Schwaiger 14576 2361 34365 7373 1.1k 59.5k
Lawrence H. Schwartz 20087 1481 15824 20632 386 50.1k
Theodore S. Lawrence 7936 4951 7740 8394 611 27.1k
Jay S. Loeffler 11562 3588 3934 5168 364 26.3k
Richard L. Wahl 8277 2223 19189 6438 528 33.0k
Zvi Fuks 11068 7145 6062 5215 403 31.5k

All Works

Loading papers...

Rankless by CCL
2026